Informative Article | Health Sciences | India | Volume 9 Issue 8, August 2020
Clinical Trials Knowhows for Novel Vaccine Development
Deepanker Bisht, Samriddhi Dubey
Abstract: Vaccination, by saving millions of lives, is unquestionably one of the biggest triumphs in the history of medicine. Numerous efforts and substantial amount of research are focused on producing an efficacious and qualified vaccine for the current pandemic of COVID-19. Leading pharmaceutical companies have started promising clinical trials worldwide recruiting healthy human volunteers to contribute and become a partner in scientific discovery. The clinical trials process includes human studies for acceptable safety and reactogenicity of a potential vaccine in Phase I trial and ensuring the proof-of-concept of the vaccine in Phase II. The final step in clinical evaluation is Phase III trial intended to provide a conclusion needed for license and marketing approval. We, in this article, have tried to address the clinical trials and evaluation process required to define the safety profile, monitoring, licensing and approval of a new vaccine candidate.
Keywords: Clinical trials, vaccine, human volunteers, COVID-19
Edition: Volume 9 Issue 8, August 2020,
Pages: 121 - 123
How to Cite this Article?
Deepanker Bisht, Samriddhi Dubey, "Clinical Trials Knowhows for Novel Vaccine Development", International Journal of Science and Research (IJSR), https://www.ijsr.net/get_abstract.php?paper_id=SR20730104750, Volume 9 Issue 8, August 2020, 121 - 123
How to Share this Article?
Similar Articles with Keyword 'Clinical'
Safety Culture: Clinical Characteristics and Prevention of Venous Catheter Infection in Critically Ill Patients
Fernanda Jorge Magalhaes, Soraia Kessia de Araujo Silva, Victor Felipe Leca Sena, Francisca Elisangela Teixeira Lima, Karla Maria Carneiro Rolim, Roberta Pinheiro Ferreira
Effect of Spirituality on Health and Physical Wellbeing in Chinese Young Adults
Zhang Qiaoyi, Guru Deo